A vertical stack of three evenly spaced horizontal lines.
The words "Business Insider"
The word "Markets Insider".
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
An icon in the shape of a calendar.
Economic
Earnings
A magnifying glass. It indicates, "Click to perform a search".
The word "Markets Insider".
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
The word Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
The word Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
The word Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
The word Commodities
News
Commodities Live
Gold
Oil
Copper
The word Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
The word Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
The word ETFs
News
ETF Finder
ETF Issuers
The word News
My Watchlist
My Watchlist
The letter F.
A stylized bird with an open mouth, tweeting.
The word "in".
A play button in the shape of a television screen.
A stylized camera.
The words "Business Insider"
© 2024
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Made in NYC
Stock quotes by
finanzen.net
Home
Stocks
Palisade Bio-stock
News for Palisade Bio
News for Palisade Bio Inc Registered Shs
GlobeNewswire
10h
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
GlobeNewswire
8d
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
GlobeNewswire
25d
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire
28d
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
GlobeNewswire
38d
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
Seeking Alpha
38d
Palisade Bio gets notice of allowance for Canadian patent covering lead product candidate
GlobeNewswire
39d
Palisade Bio to Present at the Virtual Investor Pitch Conference
GlobeNewswire
59d
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
TipRanks
63d
Buy Rating Affirmed for Palisade Bio’s PALI-2108 Amid Strong Financials and Promising Partnership
Seeking Alpha
66d
Palisade Bio GAAP EPS of -$4.59
GlobeNewswire
66d
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
InvestorPlace
67d
PALI Stock Earnings: Palisade Bio Beats EPS for Q1 2024
GlobeNewswire
73d
Palisade Bio Appoints Margery Fischbein to its Board of Directors
GlobeNewswire
73d
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
GlobeNewswire
78d
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Seeking Alpha
79d
Palisade Bio looks to raise $4M in private placement
Seeking Alpha
79d
SYT and STI among mid-day movers
GlobeNewswire
79d
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
Seeking Alpha
79d
Canopy Growth, Caredx, CytomX Therapeutics among healthcare movers
Seeking Alpha
79d
Palisade Bio stock rallies 50% premarket on colitis drug update
Seeking Alpha
87d
ING, PALI and FNCH among pre-market losers
Seeking Alpha
87d
KOPN, BTCM and CETX among mid-day movers
GlobeNewswire
87d
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Seeking Alpha
87d
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
Seeking Alpha
87d
Palisade Bio, Strand Life Sciences team up on colitis drug research
InvestorPlace
89d
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
TipRanks
93d
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
Benzinga
94d
S&P 500 Edges Lower; PacBio Shares Plunge
Benzinga
94d
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
94d
Gold Moves Higher; Morgan Stanley Earnings Top Views
Seeking Alpha
94d
JAGX, BSGM and SXTC among mid-day movers
InvestorPlace
94d
Live Nation Antitrust Probe Rattles LYV Stock. What to Know.
InvestorPlace
94d
Why Is Peraso (PRSO) Stock Up 53% Today?
Benzinga
94d
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
InvestorPlace
94d
Why Is Jaguar Health (JAGX) Stock Up 44% Today?
InvestorPlace
94d
Why Is Palisade Bio (PALI) Stock Up 57% Today?
GlobeNewswire
94d
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
Seeking Alpha
94d
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers
Seeking Alpha
94d
Palisade Bio stock rallies nearly 100% on colitis drug analysis
GlobeNewswire
99d
Palisade Bio to Participate in the Virtual Investor Lunch Break Event
Seeking Alpha
100d
Palisade Bio stock slides 8% amid colitis drug presentation
GlobeNewswire
100d
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™
Page
Page
Page
1
Page
Page